摘要
目的:对住院治疗的脑梗死患者的疗效与抗高血压药物的利用情况进行调查,分析不同抗高血压药物对脑梗死疗效的影响,为进一步改善人群高血压治疗水平提供参考.方法:应用成本-效果分析与成本-效益分析的研究方法.结果:选择的9种高血压治疗方案中,使用了新型降压药的治疗方案治愈率较高,而复方降压片与硝苯地平的成本只有36.5和12.41元.从成本-效益分析来看,倍他乐克最好,每节约1元钱需投入0.23元;卡托普利虽然提高了治愈率,但花费较大.结论:与传统降压药相比,新型降压药普遍提高了脑梗死的治愈率,而从药物经济学分析.倍他乐克最好,卡托普利花费较大.
AIM:To investigating utilization of antihypertensive drugs and curative effect of cerebral infarction of inpatients,analysis effects of antihypertensive drugs in curative effect of cerebral infarction for reference of improving the level of antihypertensive treatment. METHODS: Using cost-effectiveness analysis and cost-benefit analysis. RESULTS: In 9 kinds of curative , there were higher cure rate in the schemes which had used new type antihy-pertensive drug, the cost of tablet of compound antihypertension and nifedipine were 36. 5 yuan and 12.41 yuan. According to cost-effect analysis, betaloc was the best. Captopril im-proved cure rate, but the cost was more. CONCLUSION: The new type antihypertensive drugs improves cure rate of cerebral infarction than traditional antihypertensive drugs. Ac-cording to cost-effect analysis,betaloc is the best,the cost of captopril is more.
出处
《中国临床药学杂志》
CAS
1999年第2期112-114,共3页
Chinese Journal of Clinical Pharmacy
关键词
脑梗死
抗高血压药物
成本-效果
成本-效益
cerebral infarction
cost-effectiveness analysis
cost-benefit analysis